Type I interferon in systemic lupus erythematosus and other autoimmune diseases.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Immunity

• Publication date

  2006-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.IMMUNI.2006.08.010PMID 16979570
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• B cell targeted therapies in autoimmune diseases.

  2006cited by this paper
• Cutting Edge: Enhancement of Antibody Responses Through Direct Stimulation of B and T Cells by Type I IFN1

  2006cited by this paper
• Direct Stimulation of T Cells by Type I IFN Enhances the CD8+ T Cell Response during Cross-Priming1

  2006cited by this paper
• Extrafollicular Activation of Lymph Node B Cells by Antigen-Bearing Dendritic Cells

  2006cited by this paper
• What do mouse models teach us about human SLE?

  2006influential reference
• TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE.

  2006cited by this paper
• Genomic view of systemic autoimmunity in MRLlpr mice

  2006cited by this paper
• Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies.

  2006cited by this paper
• A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus

  2006cited by this paper
• Toll-like receptor 9 signaling protects against murine lupus.

  2006cited by this paper
• Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome.

  2006cited by this paper
• Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors.

  2006cited by this paper
• Autoreactive B Cell Responses to RNA-Related Antigens Due to TLR7 Gene Duplication

  2006cited by this paper
• Regulation of B Cell Tolerance by the Lupus Susceptibility Gene Ly108

  2006cited by this paper
• A Tlr7 translocation accelerates systemic autoimmunity in murine lupus.

  2006influential reference
• Cross-regulation of TNF and IFN-¿ in autoimmune diseases

  2005cited by this paper
• IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors.

  2005cited by this paper
• Autoantibodies make a U-turn: the toll hypothesis for autoantibody specificity

  2005cited by this paper
• RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement

  2005cited by this paper
• Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9.

  2005cited by this paper
• Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus

  2005cited by this paper
• IRF-7 is the master regulator of type-I interferon-dependent immune responses

  2005cited by this paper
• A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity

  2005cited by this paper
• Plasmacytoid predendritic cells initiate psoriasis through interferon-α production

  2005cited by this paper
• Interferon‐α/β–mediated innate immune mechanisms in dermatomyositis

  2005cited by this paper
• Defective B cell tolerance checkpoints in systemic lupus erythematosus

  2005cited by this paper
• Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays.

  2005cited by this paper
• Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus.

  2005cited by this paper
• Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection

  2005cited by this paper
• Toll-like receptor-7 modulates immune complex glomerulonephritis.

  2005cited by this paper
• Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions.

  2005cited by this paper
• Autoantibodies make a U-turn

  2005cited by this paper
• Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis.

  2005cited by this paper
• Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8

  2005cited by this paper
• Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus

  2005cited by this paper
• Interactions of DC‐SIGN with Mac‐1 and CEACAM1 regulate contact between dendritic cells and neutrophils

  2005cited by this paper
• IFN-α Induces Early Lethal Lupus in Preautoimmune (New Zealand Black × New Zealand White)F1 but Not in BALB/c Mice1

  2005cited by this paper
• The genetics of systemic lupus erythematosus.

  2005cited by this paper
• IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White) F1 but not in BALB/c mice.

  2005cited by this paper
• Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism.

  2005cited by this paper
• Cross-regulation of TNF and IFN-alpha in autoimmune diseases.

  2005cited by this paper
• Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors

  2005cited by this paper
• Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.

  2005influential reference
• Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells.

  2005cited by this paper
• Autoimmunity through cytokine-induced dendritic cell activation.

  2004cited by this paper
• Type I IFN Protects Against Murine Lupus

  2004influential reference
• Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches.

  2004cited by this paper
• In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered.

  2004cited by this paper
• Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study.

  2004cited by this paper
• Aberration of CCR7+ CD8+ memory T cells from patients with systemic lupus erythematosus: an inducer of T helper type 2 bias of CD4+ T cells

  2004cited by this paper
• T lymphocytes in systemic lupus erythematosus: an update

  2004cited by this paper
• Induction of Protective IgA by Intestinal Dendritic Cells Carrying Commensal Bacteria

  2004cited by this paper
• Toll-like Receptor 9–Dependent and –Independent Dendritic Cell Activation by Chromatin–Immunoglobulin G Complexes

  2004cited by this paper
• Type I IFN Protects Against Murine Lupus1

  2004cited by this paper
• Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

  2003cited by this paper
• Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice.

  2003cited by this paper
• Immunity

  2003cited by this paper
• Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity.

  2003cited by this paper
• G-CSF–stimulated Neutrophils Are a Prominent Source of Functional BLyS

  2003cited by this paper
• Circulating human plasmacytoid dendritic cells are highly sensitive to corticosteroid administration

  2003cited by this paper
• FcγRIIa Is Expressed on Natural IFN-α-Producing Cells (Plasmacytoid Dendritic Cells) and Is Required for the IFN-α Production Induced by Apoptotic Cells Combined with Lupus IgG 1

  2003cited by this paper
• Development of autoantibodies before the clinical onset of systemic lupus erythematosus.

  2003cited by this paper
• Tolerogenic dendritic cells.

  2003cited by this paper
• Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6.

  2003influential reference
• Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG.

  2003cited by this paper
• Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood

  2003influential reference
• Cutting Edge: Dissociation Between Autoimmune Response and Clinical Disease After Vaccination with Dendritic Cells

  2003cited by this paper
• IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities.

  2003influential reference
• Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB Mice

  2003cited by this paper
• Selective accumulation of CCR4+ T lymphocytes into renal tissue of patients with lupus nephritis.

  2002cited by this paper
• Blood dendritic cells and DC-poietins in systemic lupus erythematosus.

  2002influential reference
• Gene Expression Profiling in DQA1*0501+ Children with Untreated Dermatomyositis: A Novel Model of Pathogenesis1

  2002cited by this paper
• Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

  2002cited by this paper
• DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL

  2002influential reference
• Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo

  2001cited by this paper
• Increased Frequency of Pre-germinal Center B Cells and Plasma Cell Precursors in the Blood of Children with Systemic Lupus Erythematosus1

  2001cited by this paper
• Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

  2001cited by this paper
• HLA‐DR expression on lymphocyte subsets as a marker of disease activity in patients with systemic lupus erythematosus

  2001cited by this paper
• Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions.

  2001cited by this paper
• IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells.

  2001cited by this paper
• Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.

  2001influential reference
• Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus

  2001influential reference
• IFN-α and IL-10 Induce the Differentiation of Human Type 1 T Regulatory Cells1

  2001cited by this paper
• Effects of interferon-alpha on peripheral neutrophil counts and serum granulocyte colony-stimulating factor levels in chronic hepatitis C patients.

  2000cited by this paper
• CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling.

  2000cited by this paper
• CD8 (+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-α/β signaling

  2000cited by this paper
• Immunobiology of dendritic cells.

  2000cited by this paper
• Effects of Interferon-α on Peripheral Neutrophil Counts and Serum Granulocyte Colony-Stimulating Factor Levels in Chronic Hepatitis C Patients

  2000cited by this paper
• Experimentally Induced Recruitment of Plasmacytoid (CD123high) Dendritic Cells in Human Nasal Allergy1

  2000cited by this paper
• Changes of CD4/CD8 Ratio and Interleukin-16 in Systemic Lupus Erythematosus

  2000cited by this paper
• Influence of interferon β-1a dose frequency on PBMC cytokine secretion and biological effect markers

  1999cited by this paper
• Dendritic cells associated with plasmablast survival

  1999cited by this paper
• Type I Interferons Keep Activated T Cells Alive

  1999cited by this paper
• The nature of the principal type 1 interferon-producing cells in human blood.

  1999cited by this paper
• Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6.

  1999cited by this paper
• Cleavage by Granzyme B Is Strongly Predictive of Autoantigen Status

  1999cited by this paper
• β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6

  1999cited by this paper
• Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response.

  1998cited by this paper
• Impairment of  T and B Cell Development by Treatment with a Type I Interferon

  1998cited by this paper
• Critical role of IL-12 in dendritic cell-induced differentiation of naive B lymphocytes.

  1998influential reference

• Quantifying inflammatory resolution in human menstruation reveals disease-specific failure modes and enables a non-invasive diagnostic for endometriosis

  2026cites this paper
• IFN response regulation upon viral infections.

  2026cites this paper
• Oligoprotein type I interferon signatures, but not TREX1 variants, increase risk of systemic lupus erythematosus in UK Biobank

  2026cites this paper
• USP30-AS1 functions as a post-transcriptional amplifier of interferon signalling to drive autoimmune pathogenesis.

  2026cites this paper
• A highly prevalent lupus risk haplotype increases IRF7-dependent induction of IFN-α, enhancing antiviral defense and exacerbating autoimmunity

  2026cites this paper
• New biological agents in systemic lupus erythematosus.

  2026cites this paper
• Cytokine storm

  2026cites this paper
• Enhancing the treatment potential of IL-17 antagonism in lupus nephritis: finding the right partner

  2025cites this paper
• Progenitor cells and circulating endothelial cells are associated with disease activity and damage in systemic lupus erythematosus patients

  2025cites this paper
• THE IMPACT OF HOMOCYSTEINE IN LUPUS ERYTHEMATOSUS: A LINK OF INFLAMMATION, SKIN AND CARDIOVASCULAR RISK

  2025cites this paper
• Extracellular vesicles in skin health and diseases.

  2025cites this paper
• High interferon response signatures in SLE patient leukocytes are associated with increased transposable element expression in gene introns and intergenic regions

  2025cites this paper
• A mechanistic review–regulation of silica-induced pulmonary inflammation by IL-10 and exacerbation by Type I IFN

  2025cites this paper
• C/EBPβ deficiency enhances keratinocyte apoptosis after UVB-induced DNA damage via regulation of the type I IFN and TNF responses

  2025cites this paper
• Network pharmacology combined with the GEO database to predict the therapeutic effect of the Chinese herbal compound Biyusan on systemic lupus erythematosus (SLE)

  2025cites this paper
• The Integrated Cellular and Molecular Landscape of Autoimmunity

  2025influential citation
• Discovery of Blood-Based Proteins That Mark Benzo[a]pyrene Modulation of Autoimmunity

  2025cites this paper
• Synthetic auxotrophy reveals metabolic regulation of plasma cell generation, affinity maturation, and cytokine receptor signaling

  2025cites this paper
• Revealing the genetic and immunological crosstalk between SLE and ccRCC: An integrative genomic analysis approach

  2025cites this paper
• Identification of histone deacetylase inhibitor targeting type I interferon and B-cell abnormalities in systemic lupus erythematosus.

  2025cites this paper
• B cells promote atrial fibrillation via autoantibodies

  2025cites this paper
• E3 ligase RAD18 targets phosphorylated IRF3 to terminate IFNB1 transcription

  2025cites this paper
• Cellular and molecular determinants mediating the dysregulated germinal center immune dynamics in systemic lupus erythematosus

  2025cites this paper
• Preliminary safety and efficacy of relmacabtagene autoleucel (relma-cel) in adults with moderately to severely active systemic lupus erythematosus: a phase I dose-escalation study.

  2025cites this paper
• EGFR-STAT1 pathway drives fibrosis initiation in fibroinflammatory skin diseases

  2025cites this paper
• Immunopathogenesis and Therapeutics of Systemic Lupus Erythematosus: an Integrative Review

  2025cites this paper
• Mechanism and Target Therapy of Rituximab in Systemic Lupus Erythematosus: Literature Review

  2025cites this paper
• Mesenchymal stem cell secretome decrease the levels of anti-dsDNA antibodies, pulmonary vascular inflammation, and kidney damage and suppresses the level of C3 complement in lupus mice models

  2025cites this paper
• Distinct interferon response patterns link to increased transposable element expression in leukocytes of systemic lupus erythematosus patients

  2025cites this paper
• Occurrence and Management of Opportunistic Infections in Patients With Autoimmune Hepatitis: A Spanish Multicentre Study

  2025cites this paper
• The ubiquitin E3 ligase TRIM21 suppresses type I interferon signaling via STING degradation and ameliorates systemic autoimmunity

  2025cites this paper
• Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer

  2024cites this paper
• Comparison of efficacy discrepancy between early-phase clinical trials and phase III trials of PD-1/PD-L1 inhibitors

  2024cites this paper
• Nucleotide metabolism, leukodystrophies, and CNS pathology

  2024cites this paper
• The 100 top-cited studies in systemic lupus erythematosus: A bibliometric analysis

  2024cites this paper
• Emerging biologic therapies for systemic lupus erythematosus

  2024cites this paper
• Explainable deep neural networks for predicting sample phenotypes from single-cell transcriptomics

  2024cites this paper
• Environment and systemic autoimmune rheumatic diseases: an overview and future directions

  2024cites this paper
• cGAS-STING pathway in systemic lupus erythematosus: biological implications and therapeutic opportunities

  2024cites this paper
• Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases

  2024cites this paper
• Computational estimation of clonal diversity in autoimmunity

  2024cites this paper
• Microheterogeneity in the Kinetics and Sex-Specific Response to Type I IFN.

  2024cites this paper
• Single-cell transcriptomic analysis of hematopoietic progenitor cells from patients with systemic lupus erythematosus reveals interferon-inducible reprogramming in early progenitors

  2024cites this paper
• B-cell depletion in autoimmune diseases

  2024cites this paper
• ETV5 promotes lupus pathogenesis and follicular helper T cell differentiation by inducing osteopontin expression

  2024cites this paper
• Understanding Autoimmunity: Mechanisms, Predisposing Factors, and Cytokine Therapies

  2024cites this paper
• Repression of mRNA translation initiation by GIGYF1 via disrupting the eIF3-eIF4G1 interaction

  2024cites this paper
• Precision Medicine in Rheumatic Diseases: Unlocking the Potential of Antibody-Drug Conjugates

  2024cites this paper
• Mesenchymal stromal cell derived extracellular vesicles as a therapeutic tool: immune regulation, MSC priming, and applications to SLE

  2024cites this paper
• Caspase-mediated processing of TRBP regulates apoptosis during viral infection

  2024cites this paper
• Apoptosis of Dendritic Cells and Autoimmune Disease.

  2024cites this paper
• Cigarette Smoking and Atherosclerotic Cardiovascular Disease

  2024influential citation
• Pandemic-associated pernio harbors footprints of an abortive SARS-CoV-2 infection

  2024cites this paper
• Changes in Serum Rheumatoid Factor Following Eradication of Hepatitis C Virus Infection With Interferon or Direct Antiviral Therapy

  2024cites this paper
• Revisiting the heterogeneity of interferon-related autoimmune diseases

  2024cites this paper
• Modulation of antigen delivery and lymph node activation in nonhuman primates by saponin adjuvant saponin/monophosphoryl lipid A nanoparticle

  2024cites this paper
• Modulation of antigen delivery and lymph node activation in non-human primates by saponin adjuvant SMNP

  2024cites this paper
• The molecular subtypes of autoimmune diseases

  2024cites this paper
• Interferon-γ induces combined pyroptotic angiopathy and APOL1 expression in human kidney disease

  2024cites this paper
• Sirtuin 3 is required for the dexmedetomidine‐mediated alleviation of inflammation and oxidative stress in nephritis

  2024cites this paper
• CAR-based cell therapies for systemic lupus erythematosus

  2024cites this paper
• Deficiency of CBL and CBLB ubiquitin ligases leads to hyper T follicular helper cell responses and lupus by reducing BCL6 degradation.

  2024cites this paper
• SARS-CoV-2 viral remnants and implications for inflammation and post-acute infection sequelae

  2024cites this paper
• SPATS2L is a positive feedback regulator of the type I interferon signaling pathway and plays a vital role in lupus

  2024cites this paper
• Innovations in Cutaneous Lupus.

  2024cites this paper
• Tissue Kallikrein-1 Suppresses Type I Interferon Responses and Reduces Depressive-Like Behavior in the MRL/lpr Lupus-Prone Mouse Model

  2024cites this paper
• Correlation of Antibodies against Nuclear Antigen using Immunofluorescence Pattern and Line Immunoassay Profile in Autoimmune Diseases at a Tertiary Care Hospital, Uttarakhand, India

  2024cites this paper
• Deciphering the Etiologies of Adult Erythroderma: An Updated Guide to Presentations, Diagnostic Tools, Pathophysiologies, and Treatments

  2024cites this paper
• New approaches to the control of chronic inflammatory diseases with a focus on the endolysosomal system of immune cells

  2024cites this paper
• The STING inhibitor (ISD-017) reduces glomerulonephritis in 129.B6.Fcgr2b-deficient mice

  2024cites this paper
• The immunometabolic function of VGLL3 and female-biased autoimmunity

  2024cites this paper
• Comparison of cell type and disease subset chromatin modifications in SLE

  2024cites this paper
• Therapeutically targeting proinflammatory type I interferons in systemic lupus erythematosus: efficacy and insufficiency with a specific focus on lupus nephritis

  2024cites this paper
• Single-cell analysis in rheumatic and allergic diseases: insights for clinical practice

  2024cites this paper
• Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activity

  2024cites this paper
• Pharmacodynamics of the S1P1 receptor modulator cenerimod in a phase 2b randomised clinical trial in patients with moderate to severe SLE

  2024cites this paper
• Single-cell transcriptome landscape of circulating CD4+ T cell populations in human autoimmune diseases

  2023cites this paper
• The role of non-coding RNA in lupus nephritis

  2023cites this paper
• An immunomodulatory antibody-drug conjugate (ADC) targeting BDCA2 strongly suppresses pDC function and glucocorticoid responsive genes.

  2023cites this paper
• Post-transcriptional checkpoints in autoimmunity

  2023cites this paper
• Elevated Levels of Interferon‐α Act Directly on B Cells to Breach Multiple Tolerance Mechanisms Promoting Autoantibody Production

  2023cites this paper
• Current Knowledge of the Molecular Pathogenesis of Cutaneous Lupus Erythematosus

  2023cites this paper
• Incorporating knowledge of disease-defining hub genes and regulatory network into a machine learning-based model for predicting treatment response in lupus nephritis after the first renal flare

  2023cites this paper
• Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases, in Patients with Cardiac Issues, and in the Healthy Population

  2023cites this paper
• Brensocatib, an oral, reversible inhibitor of dipeptidyl peptidase 1, mitigates interferon-α-accelerated lupus nephritis in mice

  2023cites this paper
• CSL362 potently and specifically depletes pDCs invitro and ablates SLE-immune complex-induced IFN responses

  2023cites this paper
• Mitochondrial DNA: a novel indicator of active inflammation in ANCA-associated vasculitides

  2023cites this paper
• MicroRNA as a potential biomarker for systemic lupus erythematosus: pathogenesis and targeted therapy

  2023cites this paper
• A State-of-the-Art Review on the Recent Advances of Mesenchymal Stem Cell Therapeutic Application in Systematic Lupus Erythematosus

  2023cites this paper
• Modifying the antiviral innate immune response by selective writing, erasing, and reading of m6A on viral and cellular RNA.

  2023cites this paper
• In cis "benign" SOCS1 variants linked to enhanced interferon signaling and autoimmunity.

  2023cites this paper
• Bioinformatic analysis of immune-related transcriptome affected by IFIT1 gene in childhood systemic lupus erythematosus

  2023cites this paper
• IFN-γ: An overlooked cytokine in dermatomyositis with anti-MDA5 antibodies.

  2023cites this paper
• Serum interferon-alpha predicts in-hospital mortality in patients hospitalised with acute severe lupus

  2023cites this paper
• Drug-induced Hypersensitivity Syndrome / Drug Reaction with Eosinophilia and Systemic Symptoms. Part I. Epidemiology, Pathogenesis, Clinicopathological Features, and Prognosis.

  2023cites this paper
• From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies.

  2023cites this paper
• Type I interferon signature and cycling lymphocytes in macrophage activation syndrome

  2023cites this paper
• Multimodal repertoire analysis unveils B cell biology in immune-mediated diseases

  2023cites this paper
• Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics

  2023cites this paper
• Potential therapeutic targets of macrophages in inhibiting immune damage and fibrotic processes in musculoskeletal diseases

  2023cites this paper